RE: ORR1 Jan 2024 08:38
In February 2021 Oriole hit a market valuation of £31m, the rise caused by excellent market conditions, undervaluation to peers and a swathe of corporate activity near the Senala licence where ORR had a very strong foothold, in fact one of the largest licence areas in country.
The current market cap is now only £6m, recent news includes 2 JV's in Cameroon, hopefully to be closed imminently + we all know that the Senala JV terminates end February and the betting is, somewhat telegraphed by management, a stake sale would be their preferred option.
It is very clear Oriole is materially undervalued, this has been the case for some time but now there are significant price driving catalysts ahead, I suggested the stock will become increasingly hard to acquire in size due to these imminent news catalysts and that has proving to be the case.
A share price of .50p would deliver a market cap of only £19m, if all ducks line up with new high grade discoveries, 1p a share cannot be ruled out over the next 12 months, more-so if the Senana stake could be sold for cash IRO £5m/£10m + retaining a generous royalty interest.
I believe by end Q1 the share price will be multiples of the current .16p therefore.
DYOR etc.